Utility of disease modifying antirheumatic drugs in "sawtooth" strategy. A prospective study of early rheumatoid arthritis patients up to 15 years

Article Abstract:

The authors record effectiveness of use of disease modifying antirheumatic drugs (DMARDs), examining early use, continuing use, and sequential use for up to 15 years in patients with early rheumatoid arthritis. Of all the varieties of DMARD combinations tried, there was no single DMARD which proved superior to any other, whether measured for effectiveness, toxicity, or any other criteria.

Statistical Data Included, Evaluation, Drug therapy, Antirheumatic agents

---

T cells, fibroblast-like synoviocytes and granzyme B+ cytotoxic cells are associated with joint damage in patients with recent onset rheumatoid arthritis

Article Abstract:

Rheumatoid arthritis (RA) is a chronic inflammatory disease affecting the hands leading to disability. A study is conducted on 36 patients suffering from RA ranging from 38 to 72 years and they are observed for 58 months, the results obtained based on the methods used are discussed.

Science & research, Research, Diagnosis, T cells

---

Similar prediction of mortality by the health assessment questionnaire in patients with rheumatoid arthritis and the general population

Article Abstract:

In June 2002, information through a mailed health assessment questionnaire was examined to analyze disability in activities of daily living. It was noticed that there were 41 deaths in 404 patients suffering from rheumatoid arthritis.

Labor Distribution by Employer, Mortality, Patient outcomes, Statistics

Similar abstracts:

• Abstracts: Costs and benefits of private finance initiative schemes. Guidance on care for parents with learning disabilities
• Abstracts: Looking at treatment from the patient's perspective. Quality care not tied to financial return
• Abstracts: Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
• Abstracts: Excision margins in high-risk malignant melanoma. A pooled analysis of bone marrow micrometastasis in breast cancer
• Abstracts: Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.